Autoimmune hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman disease
Résumé
Autoimmune hypoglycemia belongs to the clinical spectrum of HHV8 1 MCD and rituximab is an effective treatment of this condition. • This rare complication is related to autoantibodies directed toward the insulin receptor and activating the insulin signaling pathway.
Domaines
| Origine | Fichiers éditeurs autorisés sur une archive ouverte |
|---|---|
| Licence |